TWENTYEIGHT HEALTH, INC. – Trademark Portfolio

Entity Type: 03

TWENTYEIGHT HEALTH, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include TWENTYEIGHT. The owner is based in Brooklyn, NY.

340 11th St Apt 4A

Brooklyn, NY 11215

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TWENTYEIGHT HEALTH, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does TWENTYEIGHT HEALTH, INC. have?

TWENTYEIGHT HEALTH, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does TWENTYEIGHT HEALTH, INC. file in?

TWENTYEIGHT HEALTH, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are TWENTYEIGHT HEALTH, INC.'s most well-known trademarks?

TWENTYEIGHT HEALTH, INC.'s registered trademark portfolio includes well-known marks such as TWENTYEIGHT. These are among 4 currently registered trademarks in the portfolio.

What is TWENTYEIGHT HEALTH, INC.'s trademark registration success rate?

TWENTYEIGHT HEALTH, INC. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.